B cells potentially play a role in the immune response to melanoma, including during treatment with immune modulators. We profiled (transcriptome analysis) effects of anti-PD-L1 antibody therapy on ge
IFN-beta treated and control PBMCs from 8 donors two groups of PBMCs from Kang et al. 2017 (https://www.nature.com/articles/nbt.4042), analyzed using the Seurat sample alignment strategy as exp
In order to assess in vivo SHM and clonal expansion among engineered B cells, we used a synonymously re-coded 3BNC117 allele.Cells were engineered as described in Nahmad et al. 2020.